Explore the intersection of healthcare, AI, and medical devices through a detailed guide for boards and CEOs. This article unveils the blind spots in healthcare innovation, emphasizing ethics, compliance, and patient focus. Learn strategies for navigating challenges, fostering ethical leadership, and driving sustainable progress in global health

Discover the vital role of real-world data (RWD) and real-world evidence (RWE) in improving drug safety, effectiveness, and informing regulatory decisions. Explore use cases and learn how RWD complements traditional clinical trials.

Discover top-10 key trends and opportunities in precision healthcare and life science for 2023. This article covers genomics, A.I., digital health, value-based care, RWD, personalized medicine, collaborative R&D, regulatory innovation, microbiome research, and blockchain technology. Stay ahead of the curve by understanding how these trends shape the future of healthcare and life sciences.

Discover how life sciences organizations can adopt a proactive approach during downsizing, focusing on seizing opportunities and learning from strategic retreats. Explore strategies such as innovation, collaboration, and adaptability to help companies thrive in a dynamic market.

Explore the differences between business improvement and transformation strategies in healthcare and life science. Learn how to leverage both approaches to drive growth, innovation, and excellence, ensuring your organization remains competitive and innovative in a rapidly evolving industry.

Explore the stages of business insolvency in healthcare and life science companies, with case studies and best practices for intervention at each phase. Learn how to build resilience, maintain strong governance and strategy, and establish a crisis management team to navigate turbulent times and emerge stronger for future success.

This article explores the concept of continuity in healthcare, its importance, measures of success, and challenges in the U.S. context. It delves into commercial practices, preventive health, economic models, and the nexus between public and private insurers, sketching a future roadmap for enhanced continuity of care.